Inventor

GRIESINGER CHRISTIAN

DE10 patents

⚠️ This page may combine multiple inventors who share the name “GRIESINGER CHRISTIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BASF AG

2 patents

US5741892AApr 21, 1998

Pentapeptides as antitumor agents

BASF AG50 citations90

US5939527AAug 17, 1999

Tetrapeptides as antitumor agents

BASF AG12 citations71

MAX PLANCK GESELLSCHAFT

2 patents

US10308671B2Jun 4, 2019

Water-soluble derivatives of 3,5-diphenyl-diazole compounds

MAX PLANCK GESELLSCHAFT1 citations58

US11180518B2Nov 23, 2021

Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma

MAX PLANCK GESELLSCHAFT0 citations39

MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V

2 patents

US9253964B2Feb 9, 2016

Mutant alpha-synuclein, and methods using same

MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V0 citations45

US9247721B2Feb 2, 2016

Transgenic non-human animal comprising a mutant alpha-synuclein

MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V0 citations45

UNIV MUENCHEN LUDWIG MAXIMILIANS

1 patent

US10071966B2Sep 11, 2018

Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases

UNIV MUENCHEN LUDWIG MAXIMILIANS5 citations65

LUDWIG MAXIMILIANS UNIV MUNCHEN

1 patent

US10435373B2Oct 8, 2019

Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases

LUDWIG MAXIMILIANS UNIV MUNCHEN2 citations59

KOREA BASIC SCIENCE INST

1 patent

US11744839B2Sep 5, 2023

Method of increasing platelet counts of a subject

KOREA BASIC SCIENCE INST0 citations52

ZWECKSTETTER MARKUS

1 patent

US8809505B2Aug 19, 2014

Mutant alpha-synuclein, and methods using same

ZWECKSTETTER MARKUS1 citations50